Cargando…

Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years

OBJECTIVE: The aim of this study is to detect breast cancer rate, nodal status, tumor size, and associated risk factors using clinical breast examination (CBE) and mammography as screening tools in women aged 40–49 years. MATERIALS AND METHODS: A total of 500 women were screened in a time period of...

Descripción completa

Detalles Bibliográficos
Autores principales: Takkar, Navneet, Kochhar, Suman, Garg, Priyanka, Pandey, A. K., Dalal, Usha Rani, Handa, Uma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367219/
https://www.ncbi.nlm.nih.gov/pubmed/28458473
http://dx.doi.org/10.4103/jmh.JMH_26_16
_version_ 1782517731840491520
author Takkar, Navneet
Kochhar, Suman
Garg, Priyanka
Pandey, A. K.
Dalal, Usha Rani
Handa, Uma
author_facet Takkar, Navneet
Kochhar, Suman
Garg, Priyanka
Pandey, A. K.
Dalal, Usha Rani
Handa, Uma
author_sort Takkar, Navneet
collection PubMed
description OBJECTIVE: The aim of this study is to detect breast cancer rate, nodal status, tumor size, and associated risk factors using clinical breast examination (CBE) and mammography as screening tools in women aged 40–49 years. MATERIALS AND METHODS: A total of 500 women were screened in a time period of 2 years, between the ages of 40–49 years for breast cancer. Screening tools used were CBE and mammography. Clinical history and risk factors related to breast cancer were recorded. CBE was performed to detect any breast pathology followed by mammographic screening. Breast Imaging Reporting and Data System (BI-RADS) mammographic density categories were used for reporting breast imaging on mammography. For women with dense breasts or an inconclusive mammography report, ultrasonography was performed to assess the lesion/s. Suspicious lesion was subjected to fine-needle aspiration cytology or an open surgical biopsy for a confirmatory diagnosis. Women with history of breast cancer were excluded from the study. RESULTS: CBE was normal in almost 90% of the women. Screening mammography revealed Breast Imaging Reporting and Data System (BI-RADS) I and BI-RADS II in 58.4% and 34.6% of women, respectively. Only 7% of women belonged to BI-RADS III and none in BI-RADS IV category. CONCLUSION: The study findings are in agreement with the recommendations of the World Health Organization, US preventive task force and UK guidelines that recommend screening mammography in women starting at 50 years.
format Online
Article
Text
id pubmed-5367219
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53672192017-04-28 Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years Takkar, Navneet Kochhar, Suman Garg, Priyanka Pandey, A. K. Dalal, Usha Rani Handa, Uma J Midlife Health Original Article OBJECTIVE: The aim of this study is to detect breast cancer rate, nodal status, tumor size, and associated risk factors using clinical breast examination (CBE) and mammography as screening tools in women aged 40–49 years. MATERIALS AND METHODS: A total of 500 women were screened in a time period of 2 years, between the ages of 40–49 years for breast cancer. Screening tools used were CBE and mammography. Clinical history and risk factors related to breast cancer were recorded. CBE was performed to detect any breast pathology followed by mammographic screening. Breast Imaging Reporting and Data System (BI-RADS) mammographic density categories were used for reporting breast imaging on mammography. For women with dense breasts or an inconclusive mammography report, ultrasonography was performed to assess the lesion/s. Suspicious lesion was subjected to fine-needle aspiration cytology or an open surgical biopsy for a confirmatory diagnosis. Women with history of breast cancer were excluded from the study. RESULTS: CBE was normal in almost 90% of the women. Screening mammography revealed Breast Imaging Reporting and Data System (BI-RADS) I and BI-RADS II in 58.4% and 34.6% of women, respectively. Only 7% of women belonged to BI-RADS III and none in BI-RADS IV category. CONCLUSION: The study findings are in agreement with the recommendations of the World Health Organization, US preventive task force and UK guidelines that recommend screening mammography in women starting at 50 years. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5367219/ /pubmed/28458473 http://dx.doi.org/10.4103/jmh.JMH_26_16 Text en Copyright: © 2017 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Takkar, Navneet
Kochhar, Suman
Garg, Priyanka
Pandey, A. K.
Dalal, Usha Rani
Handa, Uma
Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title_full Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title_fullStr Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title_full_unstemmed Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title_short Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
title_sort screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367219/
https://www.ncbi.nlm.nih.gov/pubmed/28458473
http://dx.doi.org/10.4103/jmh.JMH_26_16
work_keys_str_mv AT takkarnavneet screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years
AT kochharsuman screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years
AT gargpriyanka screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years
AT pandeyak screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years
AT dalalusharani screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years
AT handauma screeningmethodsclinicalbreastexaminationandmammographytodetectbreastcancerinwomenaged4049years